Advertisement
Largest study of its kind identifies three treatment exposures that contribute to risk
A new online calculator can determine probability of melanoma
Family history may eclipse sun exposure in some cases
Dedicated investigators and clinicians bring expertise in drug development and flexible study design
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Timing of adjuvant immunotherapy unclear for maximum overall survival
Immune therapy and targeted therapies have led to durable responses and potential cures
Study finds high levels of a CD8 T-cell subpopulation to be predictive of ICI resistance
A brief look at our programs
Overall survival benefit not established
35-year-old presents with suspected iris melanoma
Advertisement
Advertisement